FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

SUPPL AP for HERCEPTIN (TRASTUZUMAB)